Ratio of factor V activities in PT and APTT assays as a new diagnostic marker of lupus anticoagulant

Clinical and Laboratory Haematology

Volumn 21, Issue 1, 1999, Pages 45-50

  Amagai, H ^a   Kanda, T ^a   Shizuka, R ^a   Fukumura, Y ^a   Kobayashi, I ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Factor V; Lupus anticoagulant; Platelin Excel LS; Platelin plus activator; Simplastin auto

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5; HEPARIN; LUPUS ANTICOAGULANT; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING TEST; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOEMBOLISM;

EID: 0033032064     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.1999.00168.x     Document Type: Article

References (17)

1. Colman R.W. & Weinberg R.M. (1976) Factor V. Methods Enzymology 45, 107-120.
2. Denis-Magdelaine A., Flahaut A. & Verdy E. (1995) Sensitivity of sixteen APTT reagents for the presence of lupus anticoagulants. Haemostasis 25, 98-105.
3. Ehrenforth S. & Radtke K.P. (1995) Scharrer I. Acquired activated protein C-resistance in patients with lupus anticoagulants. Thrombosis Haemostasis 74, 793-796.
4. Espioza L.R. & Hartmann R.C. (1986) Significance of the lupus-anticoagulant. American Journal of Hematology 22, 331-336.
5. Exner T., Richard K.A. & Kronenberg H. (1978) A sensitive test demonstrating lupus anticoagulant and its behavioral pattern. British Journal of Haematology 40, 143-151.
6. Exner T., Triplett D.A., Taberner D. & Machin S.J. (1991) Guidelines for testing and revised criteria for lupus anticoagulants. SSC Subcommittee for the Standardization of Lupus Anticoagulants. Thrombosis Haemostasis 65, 320-322.
7. Ginsberg J.S., Brill-Edwards P., Johnston M. et al. (1992) Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross-sectional study. Blood 80, 975-980.
8. Greenquest A.C. & Colman R.W. (1975) Bovine factor V: a calcium-containing metalloprotein. Blood 46, 769-774.
9. Edson J.R., Vogt J.M. & Hasegawa D.K. (1984) Abnormal prothrombin crossed-immunoelectrophoresis in patients with lupus inhibitors. Blood 64, 807-811.
10. Machin S.F., Giddings J.C., Graeves M. et al. (1991) Guidelines on testing for the lupus anticoagulant. Journal of Clinical Pathology 44, 885-889.
11. Marciniak E. & Romond E.H. (1989) Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant. Blood 74, 2426-2429.
12. Suzuki K., Stenflo J., Dahlback B. & Toedorsson B. (1983) Inactivation of human coagulation factor V by activated protein C. Journal of Biological Chemistry 258, 1914-1918.
13. Thiagarajan P., Pengo V. & Shapiro S.S. (1986) The use of dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood 68, 869-874.
14. Thiagarajan P., Shapiro S.S. & De Marco L. (1980) Monoclonal immunoglobulin MI coagulation inhibitor with phospholipid specificity: mechanism of a lupus anticoagulant. Journal of Clinical Investigations 66, 397-402.
15. Triplett D.A. (1993) Antiphospholipid antibodies and thrombosis: a consequence, coincidence, or cause? Archives of Pathological Laboratory and Medicine 117, 78-80.
16. Triplett D.A. & Brandt J.T. (1988) Lupus anticoagulants: misnomer, paradox, riddle, epiphenomenon. Hematological Pathology 2, 121.
17. Triplett D.A., Stocker K.F., Unger G.A. & Barna L.K. (1993) The textarin/ecarin ratio: a confirmatory test for lupus anticoagulants. Thrombosis Haemostasis 70, 925-931.